Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
CT55 Biologics Sequence Review Report 2026: Cancer/testis antigen 55 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CT55 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CT45A1 Biologics Sequence Review Report 2026: Cancer/testis antigen family 45 member A1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CT45A1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CRHR2 Biologics Sequence Review Report 2026: Corticotropin-releasing hormone receptor 2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CRHR2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CR1 Biologics Sequence Review Report 2026: Complement receptor type 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CR1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CMKLR1 Biologics Sequence Review Report 2026: Chemerin-like receptor 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CMKLR1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CLNK Biologics Sequence Review Report 2026: Cytokine-dependent hematopoietic cell linker Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CLNK sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CLCF1 Biologics Sequence Review Report 2026: Cardiotrophin-like cytokine factor 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of CLCF1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
AR Biologics Sequence Review Report 2026: Androgen receptor Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of AR sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
APOBR Biologics Sequence Review Report 2026: Apolipoprotein B receptor Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of APOBR sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
APELA Biologics Sequence Review Report 2026: Apelin receptor early endogenous ligand Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of APELA sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRL3 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor L3 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRL3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRG6 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor G6 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRG6 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
12
13
14
15
16
>>
1245
>